MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

UPEXI, INC. (UPXI)

UPEXI, INC. (UPXI)

||
||

Balance Sheets Overview

Current Ratio
164.16%
Quick Ratio
163.78%
Unit: Dollar
Assets Breakdown
    • Current digital assets at fair v...
    • Digital assets at fair value, ne...
    • Deferred tax asset
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Short-term treasury debt
    • Others
Balance Sheets
2026-06-30
2025-06-30
Cash
5,778,586
2,975,150
Accounts receivable, net
97,244
157,515
Inventory, net
265,961
1,152,870
Due from vitamedica transition
10,766
228,017
Prepaid expenses and other assets
988,542
350,836
Current digital assets at fair value
-
49,913,655
Assets available for sale - building
-
0
Current digital assets at fair value
109,625,166
-
Purchase price receivable - vitamedica
0
2,000,000
Purchase price receivable - e-core
-
0
Total current assets
116,766,265
56,778,043
Property and equipment, net
208,044
2,052,573
Intangible assets, net
86,353
163,113
Goodwill
673,854
848,854
Deferred tax asset
5,948,858
5,948,858
Digital assets at fair value, net of current
55,675,516
56,083,525
Other assets
163,223
192,123
Right-of-use asset, net
598,678
1,739,755
Total other assets
-
67,028,801
Total noncurrent assets
63,354,526
-
Total assets
180,120,791
123,806,844
Accounts payable
277,644
-
Accrued compensation
5,277,309
-
Deferred revenue
4,519
-
Accrued liabilities
1,675,521
-
Accrued interest
2,349,162
-
Acquisition payable
260,652
-
Current portion of promissory notes
0
-
Short-term treasury debt
57,295,723
-
Current portion of cygnet subsidiary notes payable
3,694,721
-
Current portion of operating lease payable
295,167
-
Total current liabilities
71,130,418
-
Operating lease payable, net of current portion
362,235
-
Convertible notes payable
162,442,056
-
Total long-term liabilities
162,804,291
-
Preferred stock, 0.00001 par value, 10,000,000 shares authorized, and 150,000 shares issued and outstanding
2
-
Common stock, 0.00001 par value, 1,000,000,000 shares authorized, 78,702,358 and 38,270,571 shares issued and outstanding, as of june 30, 2026 and june 30, 2025, respectively
787
-
Additional paid in capital
252,793,813
-
Accumulated deficit
-306,608,520
-
Total stockholders' equity
-53,813,918
-
Total liabilities and stockholders' equity
180,120,791
123,806,844
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

UPXI Balance Sheet Sankey DiagramSankey diagram visualizing UPXI balance sheet for the periodCurrent digital assetsat fair value$109,625,166 (119.63%↑ Y/Y)Cash$5,778,586 (94.23%↑ Y/Y)Prepaid expenses andother assets$988,542 (181.77%↑ Y/Y)Inventory, net$265,961 (-76.93%↓ Y/Y)Accounts receivable, net$97,244 (-38.26%↓ Y/Y)Due from vitamedicatransition$10,766 (-95.28%↓ Y/Y)Digital assets at fairvalue, net of current$55,675,516 (-0.73%↓ Y/Y)Deferred tax asset$5,948,858 (0.00%↑ Y/Y)Goodwill$673,854 (-20.62%↓ Y/Y)Right-of-use asset, net$598,678 (-65.59%↓ Y/Y)Property and equipment,net$208,044 (-89.86%↓ Y/Y)Other assets$163,223 (-15.04%↓ Y/Y)Intangible assets, net$86,353 (-47.06%↓ Y/Y)Total current assets$116,766,265 (105.65%↑ Y/Y)Total noncurrentassets$63,354,526 Total assets$180,120,791 (45.49%↑ Y/Y)Accumulated deficit-$306,608,520 Total liabilities andstockholders' equity$180,120,791 (45.49%↑ Y/Y)Total stockholders'equity-$53,813,918 Additional paid in capital$252,793,813 Common stock, 0.00001par value,...$787 Preferred stock, 0.00001par value,...$2 Total long-termliabilities$162,804,291 Total currentliabilities$71,130,418 Convertible notes payable$162,442,056 Operating lease payable,net of current...$362,235 Short-term treasury debt$57,295,723 Accrued compensation$5,277,309 Current portion ofcygnet subsidiary...$3,694,721 Accrued interest$2,349,162 Accrued liabilities$1,675,521 Current portion ofoperating lease payable$295,167 Accounts payable$277,644 Acquisition payable$260,652 Deferred revenue$4,519